News
Industry observers note that in today’s undervalued Hong Kong market, Shoucheng’s large-scale repurchase sends a clear signal: the company is prepared to reward long-term investors through steady ...
Naoris Protocol, the first in production quantum-resistant blockchain and cybersecurity mesh architecture, has announced its ...
Osaka, Japan, July 29, 2025 - (JCN Newswire) - Osaka Prefecture has finalized the detailed program for the OSAKA JAPAN SDGs ...
The project is also the first grassland carbon project in China receiving both VCS certification and the Climate, Community ...
There was a turnaround in Equity in net earnings of Associates from a loss of US$0.4million in 1Q2025 to a profit of US$0.7million in 2Q2025. This resulted in a gain of US$0.6million from Investment ...
Modius's OpenData DCIM platform provides real-time insights into data center infrastructure, enabling capacity management, improved uptime and enhanced energy efficiency. With over 250 deployments ...
Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking ...
Sulfateq B.V. is an early-stage Dutch biotech company that fosters strategic collaborations with academic and industrial ...
To empower the future with intelligence, CITIC Telecom shared multiple lightweight AI+ applications that integrate the ...
Quantum Solutions previously disclosed its plan to accumulate up to 3,000 Bitcoins over the next 12 months, aiming to hedge ...
On July 18, China’s securities regulator (CSRC) announced that Unitree has completed its IPO tutoring and is now preparing for official filing. As a global leader in the shipment of quadruped and ...
ZUNVEYL was approved in July 2024 by the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate dementia of the Alzheimer’s type in adults. As a new generation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results